Mevia is an innovative brand based in Gothenburg, Sweden, dedicated to solving the problem of medication non-adherence for life science companies. They offer reliable, customized, and user-friendly end-to-end solutions, catering to the medical adherence needs of their clients. Mevia's comprehensive solution includes the Mepill Medose Application and Data Analytic Dashboard.

The company's journey began in 2014 as a spin-off from Chalmers Technical University, with a vision to address non-adherence issues. Since then, they have achieved significant milestones, such as successful real-world studies in the UK and Nordics, which demonstrated high customer satisfaction and improved adherence. Mevia has also forged collaborations with industry leaders.

In 2017, they partnered with Jones Healthcare Group to bring real-time adherence cards to North America and Europe. Additionally, their integration with one of the largest Clinical Research Organizations (CROs) globally in 2020 enables real-time adherence data in clinical trials. With a dedicated management team and testimonials from renowned organizations like Merck KGaA and AARDEX Group, Mevia sets itself apart as a trusted and innovative adherence partner.

Follow their journey and visit their office in Gothenburg to discover how Mevia can help enhance medication adherence